ペプチドリーム(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4587/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/09/11 | 日証協 | 637,052株 | -8.98% | 118,276株 | +13.55% | 669,032株 | -9.43% | 53,559株 | -58.43% |
2015/09/04 | 日証協 | 699,910株 | +18.68% | 104,164株 | -61.06% | 738,726株 | +6.99% | 128,838株 | -44.65% |
2015/08/28 | 日証協 | 589,726株 | +1.19% | 267,490株 | +3237.78% | 690,478株 | +13.92% | 232,758株 | +483.76% |
2015/08/21 | 日証協 | 582,778株 | -6.76% | 8,014株 | -96.36% | 606,098株 | -5.66% | 39,872株 | -60.91% |
2015/08/14 | 日証協 | 625,005株 | +6.15% | 220,260株 | +252.98% | 642,440株 | -4.16% | 102,004株 | -1.49% |
2015/08/07 | 日証協 | 588,800株 | -3.64% | 62,400株 | -67.9% | 670,295株 | +8.08% | 103,549株 | -27.2% |
2015/07/31 | 日証協 | 611,045株 | +14.85% | 194,400株 | +552.9% | 620,176株 | -62.29% | 142,238株 | -88.13% |
2015/07/24 | 日証協 | 532,038株 | +2.01% | 29,775株 | -48.63% | 1,644,631株 | +241% | 1,198,549株 | +1352.17% |
2015/07/17 | 日証協 | 521,569株 | -29.83% | 57,962株 | -47.82% | 482,297株 | -17.82% | 82,535株 | +116.51% |
2015/07/10 | 日証協 | 743,248株 | -22.31% | 111,089株 | -88.34% | 586,856株 | -13.21% | 38,120株 | -93.17% |
2015/07/03 | 日証協 | 956,675株 | +362.49% | 952,642株 | +713.74% | 676,171株 | +369.23% | 558,144株 | +423.99% |
2015/06/26 | 日証協 | 206,853株 | -16.19% | 117,069株 | +60.69% | 144,103株 | -34.77% | 106,518株 | +137.61% |
2015/06/19 | 日証協 | 246,825株 | -12.53% | 72,855株 | +87.84% | 220,912株 | -10.68% | 44,828株 | +21.79% |
2015/06/12 | 日証協 | 282,177株 | -2.46% | 38,785株 | +4.54% | 247,322株 | +1.56% | 36,808株 | -2.63% |
2015/06/05 | 日証協 | 289,292株 | +9.5% | 37,100株 | -47.37% | 243,534株 | +4.74% | 37,801株 | -42.8% |
2015/05/29 | 日証協 | 264,192株 | 0% | 70,487株 | 0% | 232,520株 | 0% | 66,087株 | 0% |
2015/05/15 | 日証協 | 231,058株 | -2.24% | 1,000株 | -86.67% | 210,988株 | -0.38% | 12,504株 | -25.53% |
2015/05/08 | 日証協 | 236,358株 | -3.63% | 7,500株 | -23.08% | 211,785株 | -3.25% | 16,791株 | +47.28% |
2015/05/01 | 日証協 | 245,258株 | +0.6% | 9,750株 | -81.73% | 218,894株 | -1.4% | 11,401株 | -45.48% |
※株式分割は考慮していませんのでご注意ください。
Page Top